Can Ustekinumab treat ulcerative colitis?

Ustekinumab (Ustekinumab) is a drug that targets interleukin-12 (IL-12) and interleukin-23 (IL-23) mainly reduces the abnormal inflammatory response of the immune system by inhibiting the signaling pathways of these two inflammatory factors, thereby achieving the purpose of treating autoimmune diseases. It has been widely used in the treatment of psoriasis, psoriatic arthritis and other diseases, and in recent years has also been studied and approved for the treatment of inflammatory bowel disease.

Regarding ulcerative colitis (UC), ustekinumab has shown good efficacy in multiple clinical trials. As an immunomodulator, ustekinumab can effectively reduce intestinal inflammation, relieve patients' symptoms such as diarrhea, abdominal pain and bloody stools, and promote the healing of the intestinal mucosa. In 2022, ustekinumab was approved by the U.S. FDA for the treatment of patients with moderately to severely active ulcerative colitis, marking it as one of the important biological treatment options for this disease.

Clinical data show that patients with ulcerative colitis treated with ustekinumab can see significant improvement in symptoms within 8thoughtful12 weeks, and some patients achieve clinical remission and endoscopic mucosal healing. Its efficacy is sustained and stable, and compared with traditional immunosuppressants, it is better tolerated and has a lower incidence of adverse reactions, which improves patients' quality of life. In addition, ustekinumab is administered by subcutaneous injection, which facilitates long-term management of patients.

In summary, ustekinumab can indeed be used to treat ulcerative colitis, especially for moderate to severe patients who are ineffective or intolerant to traditional treatments. Patients should follow the doctor's instructions during use and conduct regular reviews to evaluate efficacy and safety. As research continues to deepen, ustekinumab is expected to bring good news to more patients with inflammatory bowel disease and improve disease prognosis.

Reference materials:https://www.drugs.com